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S
R D < 2.0-2.4 2.5-2,9 > 3.Omm
n 3“ tos 63 18
Vessel size IS?. * 0.12” 2.25+0.15 2,73 & 0.14
Pm-stenosis
3.25 +0.21
64.1 * 9 65.4* 13.6
Max B
66.5* 12.1 67.4 + 10.1
1.89+ 0.27 1.9S+ 0.26 2.03+ 0.25 2.06+ 0.25
Burr/Artetyvls 0.74 & 0.08 O.77*O.1O 0.73+0.07 0.71 * 0.09
(MA 1.o2 *0.16* 0.89i0.12 0.74+0.10 0.s4 * 0.07
Poststenosis 20,3+ 13.6s 24.4k 16.2 29.4 + 14.3 33.9* 18
*p <0.05 vs all others;*= p <0.05 vs vessels 2.5 or >
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Referencs Diameter 2.7& 0.7
Burr:Artery 0.75+ 0.17
Bsllrxm:Artery 1.21 + 0.23
InflationPressure 3.5 * 1.8
Pra-Btano5is(%) 51. Lt13
POst-Stsnesis(%) 19+21
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Restenosis (56) No Restencsis(62) p
LAD, RCA, CX 36, 17,3 42, 12,6 NS
LesionType B2 33 (57%) 48 (77%) 0.01
c 23 (39%) 11 (160A) O.oi
CalcifiedLesion(> 10 mm) 37 (630A) 50 (81”/0) 0
Longlesion(> 10 mm) 33 (57%) 14 (23%) 0
Finallesionpost-procedure 21 *4 12A 6 0
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